ArticleEuropean journal of pediatrics2025
Overweight and obesity in early childhood and obesity at 10 years of age: a comparison of World Health Organization definitions.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The World Health Organization recommends using + 2 SD of body mass index z-score (zBMI) to define overweight/obesity (OWO) in children ages 2 to 5 years whereas + 1 SD is used as cut-point from 5 years onwards. Empirical evidence for using different cut-points across childhood is lacking. Our objective was to compare the ability of OWO in early childhood defined using zBMI cut-points at + 2 SD and + 1 SD to predict obesity at 10 years. Data from a prospective birth cohort (QLSCD) were analyzed. At ages 2.5, 3.5, and 4.5 years, children were classified as OWO based on + 2 SD and + 1 SD zBMI cut-points. At 10 years, obesity was assessed (zBMI and waist circumference). Associations between OWO (vs non-OWO) and later obesity were estimated using multivariable linear regressions. Outcome predictions for each cut-point were compared using partial eta-squared values. The sample included 1092 children (53% female). OWO in early childhood was 2-3 times more prevalent when using + 1 SD vs + 2 SD cut-points. In relation to later obesity, partial eta-squared values for both cut-points of OWO were in the small to medium effect size range (ranging from 3 to 15%), suggesting that OWO regardless of cut-point contributed only modestly to obesity measured at 10 years. However, across all time points, eta-squared values were slightly higher for OWO defined at + 1 SD vs + 2 SD, indicating a higher proportion of variance in outcomes being accounted for at zBMI + 1 SD. Conclusion: In children 2 to 5 years old, both definitions of OWO had small to modest effect sizes in relation to obesity in childhood albeit with a marginally superior predictive ability of the + 1 SD over the + 2 SD cut-point across early childhood. From a clinical perspective, using a single cut-point from early childhood onwards may be more practical to monitor growth and weight gain over time and identify children at risk of persistent obesity. What is Known: • The World Health Organization recommends using zBMI cut-points at + 2 SD for children ages 2-5 years, and + 1 SD from 5 years onwards to define overweight/obesity • Research is needed to determine which zBMI cut-point (+ 2 SD or + 1 SD) in children under 5 years best predicts subsequent obesity What is New: • Both definitions of overweight/obesity in early childhood contributed modestly to obesity at 10 years, with + 1 SD being marginally more effective than + 2 SD • Using a single cut-point at + 1 SD across childhood may be more practical for monitoring growth, weight gain, and identifying children at risk of persistent obesity.
Indexed as
Identifiers
40140102What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.